gatifloxacin has been researched along with Recrudescence in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (81.82) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaji, V; Bandyopadhyay, R; Jasmine, S; Rupali, P; Sathyendra, S; Yadav, B | 1 |
| Balasubramanian, R; Banurekha, VV; Baskaran, D; Chandrasekar, C; Charles, N; Ganapathy, S; Gangadevi, NP; Iliayas, AS; Jagannath, K; Jawahar, MS; Kumar, MM; Kumar, SR; Kumar, V; Mohan, V; Narayanan, PR; Paramasivan, CN; Parthasarathy, RT; Ponnuraja, C; Rahman, F; Ramachandran, R; Raman, B; Sakthivel, MR; Selvakumar, N; Shanmugam, G; Venkatesan, P | 1 |
| Aroonroch, R; Chongtrakool, P; Chuckpaiwong, V; Lekhanont, K; Vongthongsri, A | 1 |
| Bello, S; Torres, A | 1 |
| Dagan, R; Echols, RM; Greenberg, D; Hamed, KA; Jacobs, MR; Ledeine, JM; Leiberman, A; Leibovitz, E; Pierce, PF; Piglansky, L; Press, J; Raiz, S | 1 |
| Arguedas, A; Hamed, K; Lopez, E; Pierce, PF; Sáez-Llorens, X; Sher, L; Skuba, K | 1 |
| Arguedas, A; Echols, R; Hamed, KA; Pierce, P; Rodriguez, A; Sáez-Llorens, X; Yang, J | 1 |
| Arguedas, A; Biswas, D; Echols, R; Hamed, KA; Husseman, M; Pichichero, M; Pierce, P; Sher, L | 1 |
| Arguedas, A; Dagan, R; Echols, R; Hamed, K; Pichichero, ME; Saez-Llorens, X; Sher, L | 1 |
| Clearfield, M | 1 |
| Kirstein, JM; Mathew, CP; Orchard, D; Richard, GA; Yang, JY | 1 |
1 review(s) available for gatifloxacin and Recrudescence
| Article | Year |
|---|---|
Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure.
Topics: Anti-Infective Agents; Child; Clinical Trials as Topic; Fluoroquinolones; Gatifloxacin; Humans; Otitis Media; Recurrence; Treatment Failure | 2005 |
6 trial(s) available for gatifloxacin and Recrudescence
| Article | Year |
|---|---|
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.
Topics: Adult; Antitubercular Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Recurrence; Sputum; Treatment Outcome; Tuberculosis, Pulmonary; Young Adult | 2013 |
Bacteriologic and clinical efficacy of oral gatifloxacin for the treatment of recurrent/nonresponsive acute otitis media: an open label, noncomparative, double tympanocentesis study.
Topics: Acute Disease; Administration, Oral; Child, Preschool; Drug Administration Schedule; Female; Fluoroquinolones; Gatifloxacin; Humans; Infant; Male; Otitis Media; Recurrence; Treatment Outcome | 2003 |
Open label, multicenter study of gatifloxacin treatment of recurrent otitis media and acute otitis media treatment failure.
Topics: Acute Disease; Administration, Oral; Child; Child, Preschool; Female; Fluoroquinolones; Gatifloxacin; Humans; Infant; Male; Otitis Media; Recurrence; Treatment Failure; Treatment Outcome | 2003 |
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, Preschool; Female; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Pneumococcal Infections; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome | 2005 |
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, Preschool; Female; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Pneumococcal Infections; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome | 2005 |
Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Middle Aged; Recurrence; Treatment Outcome; Urinary Tract Infections | 2002 |
4 other study(ies) available for gatifloxacin and Recrudescence
| Article | Year |
|---|---|
Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Hospitalization; Humans; India; Male; Microbial Sensitivity Tests; Nalidixic Acid; Recurrence; Salmonella typhi; Treatment Outcome; Typhoid Fever; Young Adult | 2018 |
Pythium insidiosum keratitis in contact lens wear: a case report.
Topics: Anti-Infective Agents; Contact Lenses, Hydrophilic; Corneal Ulcer; Disposable Equipment; Drug Administration Schedule; Eye Enucleation; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Keratoplasty, Penetrating; Ophthalmic Solutions; Pythium; Recurrence; Reoperation; Young Adult | 2009 |
[Pneumococcus and quinolone resistance].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Multivariate Analysis; Mutation; Ofloxacin; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumonia, Pneumococcal; Quinolines; Recurrence; Risk Factors; Streptococcus pneumoniae | 2003 |
C-reactive protein levels and outcomes after statin therapy.
Topics: Anticholesteremic Agents; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Coronary Disease; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Multicenter Studies as Topic; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk Factors | 2006 |